<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-0420</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Cardiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Urug.Cardiol.]]></abbrev-journal-title>
<issn>1688-0420</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Uruguaya de Cardiología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-04202020000100046</article-id>
<article-id pub-id-type="doi">10.29277/cardio.35.1.5</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Valvuloplastia aórtica percutánea en la estenosis aórtica severa del adulto: indicaciones y morbimortalidad. Análisis del registro de valvuloplastias aórticas de un centro cardiovascular universitario]]></article-title>
<article-title xml:lang="en"><![CDATA[Percutaneous aortic valvuloplasty in severe adult aortic stenosis: indications, morbidity and mortality. Analysis of the aortic valvuloplasty registry of an university cardiovascular center]]></article-title>
<article-title xml:lang="pt"><![CDATA[Valvoplastia aórtica percutânea na estenose aórtica adulta grave: indicações e morbimortalidade. Análise do registro de valvoplastia aórtica do um centro cardiovascular da universidade]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Albistur]]></surname>
<given-names><![CDATA[Juan]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Loza]]></surname>
<given-names><![CDATA[Gimena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bachini]]></surname>
<given-names><![CDATA[Juan Pablo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Trujillo]]></surname>
<given-names><![CDATA[Pedro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mila]]></surname>
<given-names><![CDATA[Rafael]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Niggemeyer]]></surname>
<given-names><![CDATA[Álvaro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Durán]]></surname>
<given-names><![CDATA[Ariel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vignolo]]></surname>
<given-names><![CDATA[Gustavo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de la República Hospital de Clínicas Centro Cardiovascular Universitario]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<volume>35</volume>
<numero>1</numero>
<fpage>46</fpage>
<lpage>79</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-04202020000100046&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-04202020000100046&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-04202020000100046&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  la estenosis aórtica severa es una enfermedad frecuente, y la sustitución valvular es el único tratamiento eficaz. La valvuloplastia aórtica percutánea (VAP) tiene beneficios transitorios y su indicación está restringida a pacientes inestables como terapia puente o paliativa. A nivel nacional existe escasa evidencia sobre los resultados de esta técnica.  Objetivo: determinar la indicación, eficacia, complicaciones y mortalidad de las VAP realizadas en nuestro centro entre enero de 2006 y setiembre de 2018. Secundariamente, determinar la terapia definitiva aplicada y el tiempo transcurrido hasta la misma.  Método: estudio retrospectivo y descriptivo. Incluyó los pacientes a los que se le realizó VAP en el período. Se revisaron las historias clínicas para extracción de variables. Las variables cualitativas se presentan en valor absoluto y porcentaje; cuantitativas en mediana e intervalo intercuartilo. Se utilizó prueba de Wilcoxon para variables dependientes, tomando p&lt;0,05 como nivel de significación. Para sobrevida se realizaron curvas de Kaplan-Meier. Protocolo aprobado por el Comité de Ética institucional.  Resultados: 28 casos; 17 (60,7%) mujeres; la mediana de edad fue de 79,5 años (IQ 73-85,5). El objetivo de la VAP fue: puente a la decisión en 11 casos (39,2%), al tratamiento definitivo en 12 (42,8%) y paliativo en 5 (18%). La VAP fue considerada exitosa en 57,1% de los casos. Las indicaciones más frecuentes fueron: insuficiencia cardíaca refractaria en 10 casos (35,7%) y shock cardiogénico en 9 (32,1%). Diecinueve pacientes fallecieron (67,8%). La sobrevida fue 59 días (IQ 5-412). Seis pacientes recibieron tratamiento definitivo (cuatro recibieron implante valvular percutáneo y dos cirugía cardíaca). El tiempo de la VAP al implante percutáneo fue 233 días y 47 días a la cirugía abierta.  Conclusiones: las indicaciones más frecuentes de la VAP fueron puente a tratamiento definitivo y decisión. La VAP fue exitosa en más del 50% de los casos. Las complicaciones mayores marcaron el pronóstico. La mortalidad fue elevada en el seguimiento. Un número reducido accedió al tratamiento definitivo (predominando el implante percutáneo).]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Summary:  Introduction:  severe aortic stenosis is frequent and valve replacement is the only effective treatment. Percutaneous aortic valvuloplasty has transient benefits, and its indication is restricted to unstable patients as a bridge to other treatment or palliative therapy. In our country, there is a few evidence of this technique.  Objective: to determine the indication, efficacy, complications and mortality of percutaneous aortic valvuloplasty performed in our center between January 2006 - September 2018. Secondarily, to determine which was the definitive therapy and it´s delay.  Method: retrospective and descriptive study. All patients who received valvuloplasty during the study period were included. Clinical histories were reviewed. Qualitative variables were presented in absolute value and percentage; the quantitative ones, in median and interquartile interval. Wilcoxon test was applied to dependent variables, p &lt;0.05. Kaplan Meier curves were performed to analize survival. Protocol was approved by ethics committee.  Results: 28 cases. 17 (60.7%) were female. Average age was 79.5 years (IQ 73-85.5). The objective of percutaneous aortic valvuloplasty was bridge therapy to decision in 11 cases (39.2%), bridge to definitive treatment in 12 (42.8%) and palliative in 5 (18%). The most frequent indications were: refractory heart failure in 10 cases (35.7%) and cardiogenic shock in 9 (32.1%). Valvuloplasty was successful in 57.1% of cases. 19 patients died (67.8%). The median survival was 59 days (IQ 5-412). 6 patients received definitive treatment (4 percutaneous implantation and 2 open cardiac surgery). The time from percutaneous aortic valvuloplasty to percutaneous aortic valve implantation was 233 days and 47 days to open surgery.  Conclusions: the most frequent indications for percutaneous aortic valvuloplasty were bridge therapy to definitive treatment and decision. Percutaneous aortic valvuloplasty was successful in more than 50% of cases. Major complications determined the prognosis. Mortality was high at follow-up. A small number acceded to definitive treatment (predominantly percutaneous implantation).]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução: a estenose aórtica grave é frequente, a substituição valvar é o único tratamento efetivo. A valvoplastia aórtica percutânea tem resultados transitórios, sua indicação é restrita a pacientes instáveis como ponte ou terapia paliativa. Em nível nacional, há poucas evidências.  Objetivo: determinar a indicação, eficácia, complicações e mortalidade das valvoplastias aórticas percutâneas realizadas em nosso centro entre janeiro de 2006 a setembro de 2018. Determinar secundariamente a terapia definitiva e o tempo até ela.  Método: estudo retrospetivo, descritivo. Todos os pacientes que receberam valvuloplastia aórtica percutânea durante o período do estudo foram incluídas. Histórias clínicas foram revisadas. As variáveis qualitativas são apresentadas em valor absoluto e percentagem; os quantitativos em intervalo mediano e interquartil. O teste de Wilcoxon foi utilizado para variáveis dependentes, p &lt;0,05. Para sobrevivência, as curvas de Kaplan Meier foram realizadas. Protocolo aprobado pelo comitê de ética.  Resultados: 28 casos. 17 (60,7%) eram mulheres e a idade média foi de 79,5 anos (QI 73-85,5). O objectivo da valvoplastia foi ponte para decisão terapêutica em 11 casos (39,2%), ponte para tratamento definitivo em 12 casos (42,8%) e paliativo em 5 casos (18%). As indicações mais frequentes foram: insuficiência cardíaca refratária em 10 casos (35,7%) e choque cardiogênico em 9 casos (32,1%). A valvuloplastia foi bem sucedida em 57.1% dos casos. 19 pacientes morreram (67,8%). A mediana de sobrevivência é de 59 dias (IQ 5-412). 6 pacientes receberam tratamento definitivo (4 implantes percutâneos e 2 por cirurgia cardíaca aberta). A mediana do tempo de valvoplastia aórtica percutânea para implante de valva aórtica percutânea foi de 233 dias e cirurgia aberta de 47 dias.  Conclusões: as indicações mais frequentes para valvoplastia aórtica percutânea foram a terapia ponte para tratamento e para decisão definitiva. A valvoplastia aórtica percutânea foi bem sucedida em mais de 50%. As complicações principais marcaram o prognóstico. A mortalidade foi alta no follow-up. Um pequeno número concordou com o tratamento definitivo (predominantemente implante percutâneo).]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Estenosis de la válvula aórtica]]></kwd>
<kwd lng="es"><![CDATA[Valvuloplastia aórtica percutánea]]></kwd>
<kwd lng="es"><![CDATA[Reemplazo de la válvula aórtica transcatéter]]></kwd>
<kwd lng="en"><![CDATA[Aortic valve stenosis]]></kwd>
<kwd lng="en"><![CDATA[Percutaneous aortic valvuloplasty]]></kwd>
<kwd lng="en"><![CDATA[Transcatheter aortic valve replacement]]></kwd>
<kwd lng="pt"><![CDATA[Estenose da valva aórtica]]></kwd>
<kwd lng="pt"><![CDATA[Valvoplastia aórtica percutânea]]></kwd>
<kwd lng="pt"><![CDATA[Substituição da valva aórtica transcateter]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Osnabrugge]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mylotte]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Head]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Van Mieghem]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Nkomo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[LeReun]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aortic stenosis in the elderly disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2013</year>
<volume>62</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1002-12</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ross Jr]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Braunwald]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aortic stenosis]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>1968</year>
<volume>38</volume>
<numero>1 Suppl</numero>
<issue>1 Suppl</issue>
<page-range>61-7</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bach]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Siao]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Girard]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Duvernoy]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement the potential role of subjectively overestimated operative risk]]></article-title>
<collab>McCallister BJr.Gualano S</collab>
<source><![CDATA[Circ Cardiovasc Qual Outcomes]]></source>
<year>2009</year>
<volume>2</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>533-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baumgarther]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Falk]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Bax]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[De Bonis]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hamm]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Holm]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía ESC/EACTS 2017 sobre el tratamiento de las valvulopatías]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2018</year>
<volume>71</volume>
<numero>02</numero>
<issue>02</issue>
<page-range>110</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thourani]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Suri]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gunter]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sheng]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients]]></article-title>
<collab>O'Brien S.Ailawadi G</collab>
<source><![CDATA[Ann Thorac Surg]]></source>
<year>2015</year>
<volume>99</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>55-61</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jacobs]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Edwards]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Shahian]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Prager]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Wright]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Puskas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Successful linking of the Society of Thoracic Surgeons database to social security data to examine survival after cardiac operations]]></article-title>
<source><![CDATA[Ann Thorac Surg]]></source>
<year>2011</year>
<volume>92</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>32-7</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cribier]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Savin]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Saoudi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Rocha]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Berland]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Letac]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients an alternative to valve replacement?]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1986</year>
<volume>1</volume>
<numero>8472</numero>
<issue>8472</issue>
<page-range>63-7</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<collab>National Heart Lung and Blood Institute</collab>
<article-title xml:lang=""><![CDATA[Percutaneous balloon aortic valvuloplasty Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>1991</year>
<volume>84</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>2383-97</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lieberman]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Bashore]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Hermiller]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pieper]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Keeler]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Balloon aortic valvuloplasty in adults failure of procedure to improve long-term survival]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>1995</year>
<volume>26</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1522-8</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Keeble]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Khokhar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Akhtar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mathur]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Weerackody]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kennon]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Percutaneous balloon aortic valvuloplasty in the era of transcatheter aortic valve implantation a narrative review]]></article-title>
<source><![CDATA[Open Heart]]></source>
<year>2016</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saia]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Marrozzini]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ciuca]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Guastaroba]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Taglieri]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Palmerini]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era]]></article-title>
<source><![CDATA[Euro Intervention]]></source>
<year>2013</year>
<volume>8</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1388-97</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ben-Dor]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Maluenda]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Dvir]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Barbash]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Okubagzi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Torguson]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to transcatheter/surgical aortic valve replacement]]></article-title>
<source><![CDATA[Catheter Cardiovasc Interv]]></source>
<year>2013</year>
<volume>82</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>632-7</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alkhouli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zack]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Sarraf]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bashir]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Nishimura]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Eleid]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Morbidity and Mortality Associated With Balloon Aortic Valvuloplasty A National Perspective]]></article-title>
<source><![CDATA[Circ Cardiovasc Interv]]></source>
<year>2017</year>
<volume>10</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McKay]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Mansfield Scientific Aortic Valvuloplasty Registry overview of acute hemodynamic results and procedural complications]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>1991</year>
<volume>17</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>485-91</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hui]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Shavelle]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Cunningham]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Matthews]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Starnes]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contemporary use of balloon aortic valvuloplasty in the era of transcatheter aortic valve implantation]]></article-title>
<source><![CDATA[Tex Heart Inst J]]></source>
<year>2014</year>
<volume>41</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>469-76</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eugène]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Urena]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Abtan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Carrasco]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ghodbane]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Nataf]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effectiveness of rescue percutaneous balloon aortic valvuloplasty in patients with severe aortic stenosis and acute heart failure]]></article-title>
<source><![CDATA[Am J Cardiol]]></source>
<year>2018</year>
<volume>121</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>746-50</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Szerlip]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Arsalan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mack]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Filardo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Worley]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Am]]></article-title>
<collab>et al usefulness of balloon aortic valvuloplasty in the management of patients with aortic stenosis</collab>
<source><![CDATA[J Cardiol]]></source>
<year>2017</year>
<volume>120</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1366-72</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Gera]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ports]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Michaels]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term mortality, cause of death, and temporal trends in complications after percutaneous aortic balloon valvuloplasty for calcific aortic stenosis]]></article-title>
<source><![CDATA[J Interv Cardiol]]></source>
<year>2006</year>
<volume>19</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>269-75</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saia]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Moretti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis a new paradigm for the heart team decision making]]></article-title>
<collab>Dall'Ara G.Ciuca C.Taglieri N.Berardini A</collab>
<source><![CDATA[J Geriatr Cardiol]]></source>
<year>2016</year>
<volume>13</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>475-82</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ford]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Nguyen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Brassil]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kushwaha]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Friedman]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Allan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Balloon aortic valvuloplasty in the transcatheter valve era single centre indications and early safety data in a high risk population]]></article-title>
<source><![CDATA[Heart Lung Circ]]></source>
<year>2018</year>
<volume>27</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>595-600</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moretti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Chandran]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Vervueren]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outcomes of patients undergoing balloon aortic valvuloplasty in the TAVI era a multicenter registry]]></article-title>
<collab>D'Ascenzo F.Barbanti M.Weerackody R</collab>
<source><![CDATA[J Invasive Cardiol]]></source>
<year>2015</year>
<volume>27</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>547-53</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ben-Dor]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Pichard]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Satler]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Goldstein]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Syed]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gaglia Jr]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients]]></article-title>
<source><![CDATA[JACC Cardiovasc Interv]]></source>
<year>2010</year>
<volume>3</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1150-6</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leyes]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Cáceres]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Vignolo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Dieste]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Scola]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Seguimiento de la eficacia clínica y seguridad de la valvuloplastia aórtica percutánea con balón en pacientes con estenosis aórtica severa sintomática]]></article-title>
<source><![CDATA[Rev Urug Cardiol]]></source>
<year>2011</year>
<volume>26</volume>
<numero>Suppl 1</numero>
<issue>Suppl 1</issue>
<page-range>76-7</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Primeras experiencias nacionales con el implante percutáneo de prótesis valvulares aórticas]]></article-title>
<source><![CDATA[Rev Urug Cardiol]]></source>
<year>2010</year>
<volume>25</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>37-46</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
